Paradiem’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,719
| Closed | -$2.54M | – | 90 |
|
|
2024
Q2 | $2.54M | Sell |
7,719
-1,762
| -19% | -$580K | 0.64% | 52 |
|
|
2024
Q1 | $3.75M | Sell |
9,481
-417
| -4% | -$165K | 0.93% | 42 |
|
|
2023
Q4 | $3.49M | Sell |
9,898
-2,680
| -21% | -$944K | 0.97% | 47 |
|
|
2023
Q3 | $4.72M | Buy |
12,578
+611
| +5% | +$229K | 1.42% | 30 |
|
|
2023
Q2 | $4.58M | Sell |
11,967
-815
| -6% | -$312K | 1.3% | 30 |
|
|
2023
Q1 | $4.43M | Buy |
12,782
+1,194
| +10% | +$414K | 1.38% | 25 |
|
|
2022
Q4 | $2.73M | Sell |
11,588
-133
| -1% | -$31.3K | 1.01% | 52 |
|
|
2022
Q3 | $2.88M | Buy |
11,721
+706
| +6% | +$174K | 1.12% | 44 |
|
|
2022
Q2 | $3.33M | Buy |
11,015
+1,140
| +12% | +$345K | 1.26% | 30 |
|
|
2022
Q1 | $4.08M | Buy |
9,875
+52
| +0.5% | +$21.5K | 1.34% | 28 |
|
|
2021
Q4 | $3.86M | Buy |
9,823
+212
| +2% | +$83.4K | 1.26% | 29 |
|
|
2021
Q3 | $4.21M | Sell |
9,611
-48
| -0.5% | -$21K | 1.25% | 29 |
|
|
2021
Q2 | $4.2M | Buy |
9,659
+72
| +0.8% | +$31.3K | 1.3% | 32 |
|
|
2021
Q1 | $3.16M | Buy |
9,587
+1,700
| +22% | +$560K | 1.04% | 39 |
|
|
2020
Q4 | $2.31M | Buy |
+7,887
| New | +$2.31M | 0.98% | 49 |
|